Wei Wang

16PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 20, 2026
Adjuvant Immunotherapy Improves Esophageal Squamous Cell Carcinoma Survival After Neoadjuvant Chemoimmunotherapy: A Multicenter Real-World Study.

|Apr 15, 2025
Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis.

Wenjie Li, Wei Wang

|Nov 21, 2024
KRAS-G12 inhibitors in lung cancer therapy: unveiling the toxicity profile through a pharmacovigilance study.

Wenjie Li, Wei Wang

|Sep 12, 2024
Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system.

Wenjie Li, Ruxue Lv, Wei Wang

|Jul 27, 2024
Unravelling the obesity paradox in MASLD patients with extrahepatic cancer.

Wenjie Li, Wei Wang

|May 27, 2024
Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey.

Wenjie Li, Peixin Dong, Wei Wang

Pageof 3

Frequent Collaborators

12 joint publications

Wenjie Li

1 joint publications

Yawei Yuan

1 joint publications

Rong Wang

1 joint publications

Tadaaki Yamada